Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
Recruiting
Observational Study
Respiratory Tract Infections (RTI)
Influenza -Like Illness
Influenza
COVID - 19
RSV Infections
Rhinovirus Infection
Metapneumovirus Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25,000 (estimated)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Every year in the fall and winter, numerous respiratory viruses (such as influenza viruses, SARS-CoV-2 (COVID-19), RSV, rhinovirus, and metapneumovirus) circulate in mainland France, causing acute respiratory infections (ARIs). These viruses can cause epidemics of varying severity, requiring close monitoring to determine their circulation levels and adapt public health measures accordingly. In Fra…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* be seen by a general practitioner or pediatrician participating in the Sentinelles surveillance program;
* between week 40 (late September-early October) and week 15 (mid-April) of each year
* have an acute respiratory infection (ARI) as defined below: Sudden onset of fever (o…
Contacts